7500 ORAL Impact of independent review on efficacy outcomes in a randomised multicenter trial of trabectedin given by two dosing regimens in patients (pts) with progressing leiomyosarcomas or liposarcomas (L-sarcomas)
Demetri, G.D., Schuetze, S., Le Cesne, A., Chawla, S., Casali, P.G., Gomez, J., Nieto, A., Elsayed, Y., Izquierdo, M.A., Blay, J.Y.Том:
5
Мова:
english
Журнал:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71477-5
Date:
September, 2007
Файл:
PDF, 59 KB
english, 2007